GSK Japan Unit Files For H1N1 Vaccine Approval At Start Of Trials
This article was originally published in PharmAsia News
Executive Summary
GlaxoSmithKline has applied for Japanese approval of its H1N1 flu vaccine, filing papers just days after beginning clinical trials